 |
|
Alterations in Corneal Stromal Dendritic Cell Phenotype and Distribution in Inflammation
Pedram Hamrah, MD;
Ying Liu, MD, PhD;
Qiang Zhang, MD;
M. Reza Dana, MD
Arch Ophthalmol. 2003;121:1132-1140.
Background The normal corneal stroma is endowed with large numbers of resident dendritic cells (DCs). The purpose of this study was to examine the phenotype and distribution of these cells in inflammation.
Methods Normal and inflamed murine corneas were excised at different time points and immunofluorescence staining with multiple antibodies was performed by confocal microscopy on whole-mounted corneal stromas to characterize and evaluate the distribution of DCs in inflammation.
Results CD11c+CD11b+ myeloid DCs were present throughout the anterior stroma. In the periphery of the normal cornea, nearly one half were major histocompatibility complex (MHC) class II+CD80+CD86+, while they were uniformly MHC class II-CD80-CD86- in the center. In inflammation, in addition to a significant increase in the number of DCs, a majority up-regulated their expression of MHC class II, CD80, and CD86, indicating their state of maturation. The up-regulation of MHC class II and costimulatory molecules on DCs was seen as early as 24 hours after induction of inflammation or transplantation. In addition to the CD11c+DCs in the anterior stroma, a CD11c-CD11b+ population of monocytes/macrophages was present almost exclusively in the posterior stroma of the cornea. These cells were found throughout all layers of the stroma, and in increased numbers, after induction of inflammation.
Conclusion The present study demonstrates, for the first time, the phenotypic changes and distribution of resident stromal DCs in corneal inflammation.
Clinical Relevance These novel data suggest that the cornea is capable of participating in immune and inflammatory responses by virtue of its own heterogeneous population of DCs.
From the Laboratory of Immunology, Schepens Eye Research Institute, and the Massachusetts Eye and Ear Infirmary, and the Department of Ophthalmology, Harvard Medical School, Boston, Mass. Dr Hamrah is now with the Department of Ophthalmology, Kentucky Lions Eye Center, University of Louisville, Louisville. The authors have no relevant financial interest in this article.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Amelioration of Murine Dry Eye Disease by Topical Antagonist to Chemokine Receptor 2
Goyal et al.
Arch Ophthalmol 2009;127:882-887.
ABSTRACT
| FULL TEXT
Topical Omega-3 and Omega-6 Fatty Acids for Treatment of Dry Eye
Rashid et al.
Arch Ophthalmol 2008;126:219-225.
ABSTRACT
| FULL TEXT
Effect of the Ocular Microenvironment in Regulating Corneal Dendritic Cell Maturation
Shen et al.
Arch Ophthalmol 2007;125:908-915.
ABSTRACT
| FULL TEXT
The Chemokine Receptor CX3CR1 Mediates Homing of MHC class II-Positive Cells to the Normal Mouse Corneal Epithelium
Chinnery et al.
IOVS 2007;48:1568-1574.
ABSTRACT
| FULL TEXT
Identification of resident and inflammatory bone marrow derived cells in the sclera by bone marrow and haematopoietic stem cell transplantation
Hisatomi et al.
Br J Ophthalmol 2007;91:520-526.
ABSTRACT
| FULL TEXT
Analysis of corneal inflammation induced by cauterisation in CCR2 and MCP-1 knockout mice
Oshima et al.
Br J Ophthalmol 2006;90:218-222.
ABSTRACT
| FULL TEXT
CCR5 Chemokine Receptor Mediates Recruitment of MHC Class II-Positive Langerhans Cells in the Mouse Corneal Epithelium
Yamagami et al.
IOVS 2005;46:1201-1207.
ABSTRACT
| FULL TEXT
Hindlimb unloading depresses corneal epithelial wound healing in mice
Li et al.
J. Appl. Physiol. 2004;97:641-647.
ABSTRACT
| FULL TEXT
Corneal Antigen-Presenting Cells: Diversity, Plasticity, and Disguise The Cogan Lecture
Dana
IOVS 2004;45:722-727.
FULL TEXT
Improved Protection from Primary Ocular HSV-1 Infection and Establishment of Latency Using Multigenic DNA Vaccines
Osorio et al.
IOVS 2004;45:506-514.
ABSTRACT
| FULL TEXT
|
